Paclitaxel-eluting balloon catheter - Eurocor/Biosensors International Group

Drug Profile

Paclitaxel-eluting balloon catheter - Eurocor/Biosensors International Group

Alternative Names: BioPath 014; BioPath 035; BioStream; FREEWAY; FREEWAY 014; Freeway 014 paclitaxel releasing balloon catheter; FREEWAY 035; Freeway 035 paclitaxel releasing balloon catheter; Freeway paclitaxel balloon catheter

Latest Information Update: 14 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eurocor
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Platelet-derived growth factor inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Peripheral arterial occlusive disorders

Most Recent Events

  • 30 May 2013 Biomarkers information updated
  • 01 May 2011 Phase-III clinical trials in Peripheral arterial occlusive disorders in Colombia, Germany, Italy, Spain and Austria (Intra-arterial) (NCT01960647)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top